Literature DB >> 9261047

Posttransplantation lymphoproliferative disorder in a renal allograft recipient.

S Goral1, R Felgar, S Shappell.   

Abstract

As a complication of immunosuppressive therapy, solid organ and bone marrow transplant recipients have an increased risk of developing post transplant lymphoproliferative disorder (PTLD). Epstein-Barr virus (EBV) infection and the degree of immunosuppression have been identified as risk factors for the development of this complication. The clinical presentation includes a spectrum of disorders ranging from a benign infectious mononucleosis-like syndrome with fever and cervical adenopathy to multiorgan failure leading to death. Although, T-cell lesions have been described, PTLD is usually associated with a polyclonal or monoclonal B-cell proliferation. In this report, we present a renal transplant recipient with a perirenal mass diagnosed as PTLD.

Entities:  

Mesh:

Year:  1997        PMID: 9261047     DOI: 10.1016/s0272-6386(97)90071-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

1.  Papillary renal cell carcinoma in allograft kidney.

Authors:  Catherine Roy; Sofiane El Ghali; Xavier Buy; Véronique Lindner; Afshin Gangi
Journal:  Eur Radiol       Date:  2004-09-17       Impact factor: 5.315

2.  Lymphoproliferative disorder presenting as a tumor of the renal allograft.

Authors:  S M Moudouni; M Tligui; J D Doublet; F Haab; B Gattegno; Ph Thibault
Journal:  Int Urol Nephrol       Date:  2006-12-08       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.